Q1 2025 Holdings
Filed 2025-05-15 | 46 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $260.2M | 11,895,808 | 15.4% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $211.9M | 1,706,469 | 12.6% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $205.6M | 17,259,548 | 12.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $146.5M | 7,880,094 | 8.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $143.8M | 4,288,120 | 8.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $143.4M | 11,584,280 | 8.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $82.5M | 1,292,386 | 4.9% |
| Xencor Inc(XNCR) | COM | 98401F105 | $65.4M | 6,144,767 | 3.9% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $47.3M | 1,389,276 | 2.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $42.3M | 3,988,971 | 2.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $39.7M | 1,469,818 | 2.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $27.5M | 4,079,415 | 1.6% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $25.2M | 1,939,288 | 1.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $24.8M | 75,000 | 1.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $19.1M | 3,418,068 | 1.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $17.8M | 440,000 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.4M | 2,640,298 | 1.0% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $16.6M | 935,121 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $16.5M | 557,576 | 1.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $14.9M | 1,271,342 | 0.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $14.6M | 10,630,736 | 0.9% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $13.2M | 3,917,546 | 0.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $10.3M | 526,685 | 0.6% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $9.3M | 1,259,273 | 0.6% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $8.3M | 1,462,328 | 0.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $8.3M | 850,341 | 0.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $7.7M | 910,000 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $6.8M | 862,068 | 0.4% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.7M | 1,250,000 | 0.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $5.4M | 27,404,070 | 0.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.9M | 155,006 | 0.2% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $3.7M | 2,082,000 | 0.2% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $3.4M | 573,183 | 0.2% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.8M | 744,450 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.9M | 187,500 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $1.7M | 963,333 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $1.7M | 641,426 | 0.1% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $1.6M | 201,718 | 0.1% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $1.4M | 135,000 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $1.4M | 700,000 | 0.1% |
| Metsera Inc | COM | 59267L107 | $1.4M | 50,000 | 0.1% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $914.7K | 662,833 | 0.1% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $777.3K | 66,665 | 0.0% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $730.7K | 88,569 | 0.0% |
| Eton Pharmaceuticals Inc(ETON)Call | COM | 29772L108 | $655.5K | 50,500 | 0.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $367.2K | 60,000 | 0.0% |